Chapel Hill’s WomanCare Global (womancareglobal.com) expanded its global product portfolio to include Roselle®, a combined oral contraceptive pill, and Optinor®, a progesterone-only emergency contraception pill. Both are included in the WHO Interagency List of Essential Medicines for Reproductive Health. WomanCare Global will market these products to public- and private-sector markets worldwide via its global supply chain and logistics network. Â